The board of directors of Thai listed property developer Nusasiri Pcl gave the green light to purchase 48.8 million shares, equivalent to 61 per cent, in Panacee Medical Hong Kong Ltd with total investment of HK$48.8 million ($6.3 million).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
